NCT04397406

Dexmedetomidine or Fentanyl as Additives to Epidural Levobupivacaine in Painless Labor

Role of Dexmedetomidine or Fentanyl as Additives to Epidural Levobupivacaine in Painless Labor: A Double Blind Randomized Controlled Study

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 90 (actual)
• Sponsor: Tanta University · Academic / Other
• Sex: All
• Age: 21 Years – 41 Years
• Healthy volunteers: Not accepted

Summary

Central neuraxial analgesia has been extensively used for labor analgesia and is currently the gold standard technique for pain control in obstetrics. The aim of the study will be to compare the role of dexmedetomidine or fentanyl as additives to epidural levobupivacaine in painless vaginal delivery as regard maternal analgesia and safety.

Conditions

• Epidural Analgesia
• Painless Labor
• Dexmedetomidine
• Fentanyl
• Levobupivacaine

Interventions

Type	Name	Description
DRUG	levobupivacaine	The patients will receive 15 ml of 0.125% levobupivacaine.
DRUG	Dexmedetomidine	The patients will receive 13 ml of 0.125% levobupivacaine and 0.5μg/kg dexmedetomidine diluted in 2 ml saline.
DRUG	Fentanyl	The patients will receive 13 ml of 0.125% levobupivacaine and 25μg fentanyl diluted in 2 ml saline.

Timeline

• Start date: 2020-07-01
• Primary completion: 2021-10-31
• Completion: 2021-10-31
• First posted: 2020-05-21
• Last updated: 2022-03-28

Locations

1 site across 1 country: Egypt